Post-approval studies in US are "vital to enhancing patient safety"
- Gottlieb S. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs. Internet Document : 16 Nov 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626090.htm
© Springer Nature Switzerland AG 2018